Adderall vs Vyvanse

Adderall and Vyvanse are both prescription amphetamines for ADHD, but they differ in form, speed, and how long they last. Both can build dependence, and the prodrug design of Vyvanse lowers that risk without erasing it.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

How Adderall and Vyvanse Compare

Adderall and Vyvanse are both prescription amphetamines used to treat ADHD, so they are cousins in the same drug family rather than rivals from different worlds[1]. What separates them is form and timing, not their basic chemistry.

If you landed here comparing two medicines a doctor mentioned, or weighing which one carries more risk of dependence, both questions are fair. The real answer to which one is better is that it depends on the person, and that call belongs to your prescriber.

Worried about your Adderall or Vyvanse use? Talk to your prescriber before you stop. Call 988 if the crash brings thoughts of suicide.
If someone has taken far more Adderall or Vyvanse than prescribed and has chest pain, a pounding or irregular heartbeat, or is dangerously overheated, call 911. A stimulant overdose strains the heart and needs a hospital.

What to do:

  • Talk to your prescriber before you stop. A dose review or a planned step-down is safer and far more comfortable than stopping on your own. Find treatment that fits →
  • If coming off either drug brings a heavy crash with thoughts of suicide, call or text 988 (Suicide & Crisis Lifeline), any time. That low lifts.
  • Don’t buy either drug outside a pharmacy to fill a gap. Pills sold online or on the street are often counterfeit and can contain other, stronger drugs.

Find treatment today →

AddictionHelp.com Fast Facts
  • Both are amphetamines. Adderall is mixed amphetamine salts and Vyvanse is lisdexamfetamine, a prodrug the body turns into dextroamphetamine, so both deliver amphetamine to the brain[2][3].
  • The main difference is speed and length. Adderall’s immediate-release form works fast and wears off in hours, while Vyvanse releases slowly for one long, once-daily stretch[2][3].
  • Both are Schedule II controlled substances. That is the tier reserved for medicines with real value and a high potential for dependence[4].
  • Vyvanse’s prodrug design lowers abuse potential but does not remove it. Both drugs still build tolerance and dependence and are misused, most often by mouth[5][6].
  • Only Vyvanse is approved for binge eating disorder; both are approved for ADHD[7].

Both Are Amphetamines in Different Forms

The single fact that explains the most is that both drugs are amphetamines. Adderall is mixed amphetamine salts, a blend of dextroamphetamine and levoamphetamine, while Vyvanse is lisdexamfetamine, an inactive molecule the body converts into pure dextroamphetamine[2][3].

What reaches the brain is real amphetamine in both cases, so their core effects and core risks overlap heavily[5]. The differences that matter are how fast the drug arrives and how long it stays, and those flow from the form each one takes.

The Side-by-Side Difference

Here is how the two line up on the features people actually compare[2][3][7]:

Feature Adderall Vyvanse
Active ingredient Mixed amphetamine salts (dextroamphetamine and levoamphetamine) Lisdexamfetamine, converted to dextroamphetamine
Drug class Amphetamine, a central nervous system stimulant Amphetamine, a central nervous system stimulant
Formulations Immediate-release tablet and once-daily XR capsule One once-daily capsule or chewable tablet
Onset Fast; immediate-release begins working within about an hour Gradual; the prodrug must be converted first
Duration About 4 to 6 hours (IR) or 10 to 12 hours (XR) About 13 to 14 hours from one morning dose
Typical dosing IR one to three times a day; XR once each morning Once each morning
Approved uses ADHD ADHD and moderate-to-severe binge eating disorder
Abuse potential High; Schedule II, faster forms carry more misuse pull High; Schedule II, prodrug design lowers but does not erase it

Read down the two columns and the pattern is clear. Adderall gives a prescriber more flexibility on timing, with a fast pill and a longer capsule, while Vyvanse trades that flexibility for one smooth, long, once-daily curve[2][3].

What Sets the Two Drugs Apart

Both drugs end up delivering dextroamphetamine, but they take very different routes to get there, and that route is the whole story of how each one feels[5]. One arrives quickly and leaves; the other is released on a slow, built-in timer.

Same Stimulant, Different ClockAdderall and Vyvanse deliver the same active stimulant, dextroamphetamine. What differs is the clock. Adderall can arrive fast, while Vyvanse is engineered to release slowly, which is why one feels sharper and the other steadier.

Adderall Is Mixed Amphetamine Salts

Adderall is a blend of four amphetamine salts that together act as dextroamphetamine and levoamphetamine[2]. It comes in two forms. The immediate-release tablet works within about an hour and fades in four to six hours, which is why it is often taken more than once a day.

The once-daily extended-release capsule, Adderall XR, packs the same medicine into a slow-release shell so a single morning dose covers most of the day[2]. A 20-milligram XR capsule was built to match two 10-milligram immediate-release doses taken hours apart[2].

Vyvanse Is a Prodrug That Releases Slowly

Vyvanse is lisdexamfetamine, a prodrug that does nothing until the body breaks it apart[3]. Enzymes in the blood slowly cut it into plain dextroamphetamine, the same active stimulant Adderall delivers, so the release is gradual rather than a spike[3].

Because the drug has to be converted first, it releases at a steady pace and runs roughly 13 to 14 hours from one morning dose[3]. That slow conversion is also what gives Vyvanse its built-in resistance to misuse, a point that matters when weighing addiction risk[5].

What Each Drug Is Approved to Treat

Naming what these drugs are for matters, because a medicine that helps you is not the same as a drug you are abusing[1]. Most people on either one are taking it for a real, diagnosed reason.

Ask Your Prescriber Which FitsIf you are choosing between the two, that is a conversation for your prescriber. Dose, timing, other medicines, and whether binge eating is in the picture all shape which drug fits you, and none of it is a decision to make alone.

Both Treat ADHD

For attention-deficit hyperactivity disorder, stimulants are the first-line treatment in children, adolescents, and adults, and both Adderall and Vyvanse reliably reduce inattention and impulsivity[6]. They work by raising dopamine and noradrenaline in the brain, which sharpens focus[8].

Even taken exactly as directed, a stimulant raises heart rate and blood pressure, which is why prescribers screen for heart problems before starting either drug and keep an eye on it afterward[9]. For the right person, the benefit is well established.

Only Vyvanse Is Approved for Binge Eating Disorder

Here the two part ways. Vyvanse is also approved for moderate-to-severe binge eating disorder in adults, and it is in fact the only medication the FDA has approved for that condition[7]. Adderall is not approved for it.

Approval rested on two large phase 3 trials in which lisdexamfetamine cut the number of binge-eating days per week significantly more than a placebo[10]. That use catches people off guard, because it means an amphetamine can be prescribed for an eating problem rather than for attention.

How They Compare on Addiction Risk

This is the comparison that brings many people here, so here is the direct answer. Both drugs can be addictive, and neither one is a safe-because-prescribed exception[4]. They are both amphetamines, and the government classes both as Schedule II controlled substances precisely because they carry a high potential for dependence[11].

Dependence Is Not the Same as AddictionYou can be physically dependent on either drug, taking it exactly as prescribed, without being addicted, which means compulsive use despite harm. Dependence is expected with regular stimulant use. Both are treatable, and neither means you failed.

Both Build Tolerance and Dependence

Take any amphetamine regularly and the brain adjusts to the steady chemical push. The same dose gradually does less, which is tolerance, and the body comes to expect the drug, which is physical dependence[4]. This happens with both Adderall and Vyvanse.

None of this is a willpower problem. It is the predictable biology of a nervous system adapting to a stimulant that is always present[8]. Tolerance is also the pressure that tempts people to creep the dose up on their own, which is where trouble often starts.

Vyvanse’s Prodrug Design Lowers Abuse Potential

This is the one place the two genuinely differ on risk. Vyvanse’s prodrug engineering makes it harder to abuse than fast-acting amphetamine, because the slow conversion happens no matter how the drug is taken[5]. Snorting or injecting it does not buy the fast rush that misuse chases[12].

That advantage has a hard limit. Lower abuse potential is not zero abuse potential, and Vyvanse still builds tolerance and dependence and is misused, most often by swallowing more than prescribed[5][6]. Adderall’s immediate-release form arrives faster[2], and with stimulants a faster rise carries more misuse pull than a slow-release form[5].

The balanced picture is this. Vyvanse is the harder of the two to abuse, but both are Schedule II amphetamines that can take hold, and being prescribed either one is never a guarantee against dependence[4].

Signs Either Drug Has Become a Problem

Tolerance and physical dependence on their own are expected responses to a stimulant. The line worth watching is behavioral, the point where a prescription you were managing starts managing you[13].

Noticing Is the Turn, Not the FailureNoticing that Adderall or Vyvanse has more of a grip than you meant it to is not a failure. It is the moment things start to turn. People who get free almost always start right here, by being straight with themselves.

Behavioral Warning Signs to Watch For

The clearest signals are about how the drug is used, not simply that you take it. Watch for the patterns that people in stimulant recovery describe most often[13][14]:

  • Taking more than prescribed, or running out of the prescription early
  • Using it for reasons it wasn’t prescribed for — to study, to work late, or to lose weight
  • Needing it to function, so ordinary days feel impossible without a dose
  • Getting it from more than one place, such as several prescribers or someone else’s supply
  • Trying to cut down and not managing it, or feeling anxious as the next dose nears
  • Keeping it quiet, hiding how much you take from people close to you

Immediate-release Adderall is misused somewhat more than long-acting forms, but no formulation is misuse-proof, and Vyvanse users land in these same patterns[6]. The signs matter more than the drug’s brand name.

When Dependence Tips Into Addiction

The shift from dependence to addiction is the shift from a body that has adapted to behavior you can no longer steer. Clinicians call the full pattern a stimulant use disorder, and it is defined by loss of control, craving, and continued use despite clear harm[13].

That pattern looks the same whether the drug is Adderall or Vyvanse, because both are amphetamines acting on the same reward pathway[5]. If that pull has taken over, it is a signal to reach for help, not to hide.

What Stopping Either Drug Feels Like

When a dose of either amphetamine wears off, it takes the borrowed energy with it. That downswing is the crash, and it is the same basic experience whether you were taking Adderall or Vyvanse[15].

The Crash Is the Brain RefillingThe crash is not proof you cannot live without the drug. It is your brain running low on the dopamine the stimulant pushed it to spend. That well refills. The heavy days lift, and the craving fades with them.

What the Crash Feels Like

Amphetamine withdrawal is more a heavy fog than a physical danger, and it centers on the mood and energy the drug had been propping up[15].

Common features include:

  • Deep fatigue and long, heavy sleep once the stimulant clears
  • Low, flat, or depressed mood, sometimes with tearfulness
  • Strong craving for another dose to lift the fog
  • Increased hunger and a slowed, sluggish feeling
  • Trouble concentrating and a sense that nothing is enjoyable

Unlike alcohol or benzodiazepine withdrawal, a stimulant crash is not usually medically dangerous, but the low can be sharp enough to bring thoughts of suicide in some people, which is when the 988 line matters[15]. The craving it drives is the main reason people go back.

Why a Planned Step-Down Beats Stopping Suddenly

Because both drugs are prescriptions, the safest first move is the same for each. Talk to your prescriber before you stop, because a dose review or a planned step-down is more comfortable than stopping abruptly on your own. Neither drug is dangerous to stop the way alcohol or a benzodiazepine can be, yet a plan still smooths the crash[15].

The one thing to avoid is quietly changing your dose alone. Bring the prescriber in, even if the reason you want to stop is that use got away from you, because that conversation is where a safe plan starts. Nothing about it gets you in trouble.

How Addiction to Either Drug Is Treated

Here is the hopeful center of all of this. A drifting relationship with Adderall or Vyvanse is treatable, the approach is well understood, and recovery is the expected outcome rather than the exception[16].

Start By Talking With Your Prescriber

Because both drugs are prescriptions, the first move for most people is the simplest one, an open conversation with the doctor who prescribes it. A prescriber can review whether the dose still fits, plan a gradual step-down, or switch approaches, and doing it with medical guidance beats stopping on your own.

Contingency Management Has the Strongest Evidence

For a use disorder that has taken on a life of its own, the treatment with the best track record is contingency management, a behavioral therapy that gives concrete rewards for verified drug-free tests[17]. Because no medication treats stimulant addiction the way methadone treats opioids, this behavioral approach is the real medicine here[16].

Across many trials, contingency management holds the largest effect of any treatment studied for stimulant use, and it works because it rewards the very behavior the drug hijacked[16]. Paired with counseling such as cognitive behavioral therapy, it gives people a repeatable reason to stay stopped.

Approach What It Is The Evidence
Talk to the prescriber A dose review, a planned step-down, or a switch The first step when prescribed use has drifted
Contingency management Small, growing rewards for drug-free tests Strongest evidence for stimulant use disorder
Cognitive behavioral therapy Skills to spot triggers and prevent relapse Effective, and best paired with incentives
Approved medication A methadone-style prescription None exists for stimulant addiction

The wider picture of contingency management is worth understanding in full, because it carries the strongest evidence for stepping back from either drug[17].

Getting Help for Adderall or Vyvanse Addiction

If either drug has taken more of your life than you meant it to, hold onto this. It is a treatable condition, stopping safely is entirely possible, and the way people describe the other side is steadier, not emptier.

The medicine was supposed to help you function, and recovery is about getting that steadiness back without the drug running the day. The path is the same whether you followed every instruction or things slipped out of your hands.

Talk to your prescriber, get into behavioral treatment that fits the science rather than a promised pill, and lean on the support that carries you through the crash. Start today, and the pull that feels permanent right now begins to loosen.

More on the two drugs and the path out:

Whenever you are ready to take the first real step, free and confidential help is waiting.

Get matched with treatment that fits your life →

Frequently asked questions

What Is the Main Difference Between Adderall and Vyvanse?

Both are prescription amphetamines for ADHD, so the difference is form and timing, not basic chemistry. Adderall is mixed amphetamine salts and comes as a fast immediate-release tablet or a once-daily XR capsule[2]. Vyvanse is lisdexamfetamine, a prodrug the body converts slowly into dextroamphetamine, giving one long, once-daily effect of about 13 to 14 hours[3]. Adderall arrives faster and can be dosed more flexibly, while Vyvanse trades that for a single smooth curve. Vyvanse is also approved for binge eating disorder, and Adderall is not[7].

Is Adderall or Vyvanse More Addictive?

Both are Schedule II amphetamines that build tolerance and dependence, so neither is a safe-because-prescribed exception[4][11]. Vyvanse is the harder of the two to abuse, because its prodrug design releases the stimulant slowly no matter how it is taken, so snorting or injecting it does not produce the fast rush misuse chases[12][5]. That lowers abuse potential but does not erase it. Adderall’s immediate-release form arrives faster, which carries more misuse pull, though both drugs are misused, most often by mouth[6].

Which Is Better for ADHD, Adderall or Vyvanse?

There is no single winner, and which one fits is a decision for your prescriber. Both are first-line stimulants that reliably reduce inattention and impulsivity in ADHD[6]. The choice usually comes down to how fast and how long you need coverage, how you respond, other medicines you take, and whether binge eating disorder is also in the picture, since only Vyvanse is approved for it[7]. Adderall offers more timing flexibility with its immediate-release and XR forms, while Vyvanse gives one steady once-daily effect[2][3].

Can You Get Dependent on Vyvanse Even Though It Is a Prodrug?

Yes. The prodrug design lowers abuse potential but does not remove dependence[5]. Vyvanse is still an amphetamine, and taken regularly it builds tolerance, so the same dose does less, and physical dependence, so the body protests when it is missing[4]. That is the biology of a nervous system adapting to a stimulant, not a personal weakness. The behavioral warning signs to watch for are taking more than prescribed, using it for reasons it wasn’t prescribed for, and needing it to get through an ordinary day[13].

What Happens When You Stop Adderall or Vyvanse?

Stopping either amphetamine brings a crash rather than a physically dangerous withdrawal. Common features are deep fatigue and long sleep, a low or depressed mood, increased hunger, trouble concentrating, and strong craving for another dose[15]. Unlike alcohol or benzodiazepine withdrawal, a stimulant crash is not usually medically dangerous, but the low can be sharp enough to bring thoughts of suicide in some people, which is when the 988 line matters. The craving is the main driver of relapse, so support helps you ride it out. Because both are prescriptions, talk to your prescriber before stopping.

How Is Addiction to Adderall or Vyvanse Treated?

For prescribed use that has drifted, the first step is an open conversation with the prescriber about a dose review or a planned step-down. For a full stimulant use disorder, treatment is behavioral, because no medication treats stimulant addiction the way methadone treats opioids[16]. Contingency management, which rewards verified drug-free tests, holds the strongest evidence, and it works best paired with counseling[17]. Recovery is the expected outcome, and you can find treatment and people who can help at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

17 Sources
  1. Rzeszutek M, Wolańczyk T (2025). Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns-A Narrative Review. Journal of clinical medicine. https://doi.org/10.3390/jcm14207338
  2. Tulloch SJ, Zhang Y, McLean A, Wolf KN (2002). SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy. https://doi.org/10.1592/phco.22.16.1405.33687
  3. Steer C, Froelich J, Soutullo CA, Johnson M, Shaw M (2012). Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder. CNS drugs. https://doi.org/10.2165/11634340-000000000-00000
  4. Moore TJ, Wirtz PW, Curran JN, Alexander GC (2023). Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open. https://doi.org/10.1136/bmjopen-2022-069668
  5. Heal DJ, Smith SL, Gosden J, Nutt DJ (2013). Amphetamine, past and present – a pharmacological and clinical perspective. Journal of psychopharmacology. https://doi.org/10.1177/0269881113482532
  6. Weyandt LL, Oster DR, Marraccini ME, Gudmundsdottir BG, Munro BA, Zavras BM, et al (2014). Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychology research and behavior management. https://doi.org/10.2147/prbm.s47013
  7. McElroy SL, Guerdjikova AI, Mori N, Munoz MR, Keck PE (2015). Overview of the treatment of binge eating disorder. CNS spectrums. https://doi.org/10.1017/S1092852915000759
  8. Heal DJ, Cheetham SC, Smith SL (2009). The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2009.08.020
  9. Morrow JP, Moreton U, Xu T, Tatonetti NP, Wang Y, Walsh BT (2025). The Association Between Stimulant Medication Use and Mortality. Journal of clinical psychopharmacology. https://doi.org/10.1097/jcp.0000000000002066
  10. McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M (2015). Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials. Neuropsychopharmacology. https://doi.org/10.1038/npp.2015.275
  11. Magnotti S, Beatty A, Bickford E, Channell I, Weyandt L (2023). Prescription Stimulant Misuse Among Nursing Students: A Systematic Review. Journal of addictions nursing. https://doi.org/10.1097/jan.0000000000000539
  12. Jasinski DR, Krishnan S (2008). Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. Journal of psychopharmacology. https://doi.org/10.1177/0269881108093841
  13. Kasson E, Filiatreau LM, Davet K, Kaiser N, Sirko G, Bekele M, et al (2024). Examining Symptoms of Stimulant Misuse and Community Support Among Members of a Recovery-Oriented Online Community. Journal of psychoactive drugs. https://doi.org/10.1080/02791072.2023.2228781
  14. Burtner J, Behling M, Cassidy T, Butler SF (2018). Prevalence of nonmedical use and routes of administration for prescription stimulant medications among adults in a substance abuse treatment population. Journal of addictive diseases. https://doi.org/10.1080/10550887.2018.1512825
  15. Shoptaw SJ, Kao U, Heinzerling K, Ling W (2009). Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003021.pub2
  16. Minozzi S, Saulle R, Amato L, Traccis F, Agabio R (2024). Psychosocial interventions for stimulant use disorder. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011866.pub3
  17. Freese TE, Rutkowski BA, Peck JA, Urada D, Clark HW, Bland AN, et al (2023). Recovery incentives program: California's contingency management benefit. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2023.107703
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.